Table 3

- Distribution of survival status in relation to baseline blood work-ups in the study individuals (N=248).

Parameter	Survivals		Non-survivors		Long rank test	P-value
Parameter	n	%	n	%	Long rank test	P-value
*Hemoglobin*
Normal	165	89.2	20	10.8	6.49	0.01^*
Low	38	60.3	25	39.7	6.49	0.01^*
*White blood cells*
Normal	12	92.3	1	7.7	1.17	0.28
Leukocytosis	188	81.0	44	19.0	1.17	0.28
*Ferritin*
Normal	33	97.1	1	2.9	2.82	0.09
High	48	61.5	30	38.5	2.82	0.09
*Platelets*
Low	36	80.0	9	20.0	2.54	0.28
Normal	142	80.7	34	19.3
High	21	91.3	2	8.7
*aPTT*
Low	13	92.9	1	7.1	3.83	0.14
Normal	102	77.3	30	22.7
High	7	33.3	14	66.7
*PTT*
Normal	88	81.5	20	18.5	2.26	0.13
High	33	56.9	25	43.1	2.26	0.13
*INR*
Low	18	78.3	5	21.7	0.31	0.85
Normal	39	76.5	12	23.5
High	65	69.9	28	30.1
*D-Dimer*
Normal	52	100.0	0	0.0	9.08	0.002^*
High	151	77.0	45	23.0	9.08	0.002^*
*Glucose*
Normal	51	86.4	8	13.6	1.92	0.16
High	82	70.1	35	29.9	1.92	0.16
*Hemoglobin A1C*
Normal	9	100.0	0	0.0	0.62	0.43
High	36	83.7	7	16.3	0.62	0.43

↵ ^* Statistically significant at p<0.05. PTT: partial thromboplastin time, aPTT: activated partial thromboplastin time, INR: international normalized ratio